Data/Analytics

//Data/Analytics
All Articles
July 16, 2019

California’s New Data Privacy Law: New Thinking on its Implications for Pharma

Last fall, we published a POV called “Should Pharma Care About California’s New Data Privacy Law?” Since then, we’ve been monitoring the legislative process and the discussions and reactions of opinion leaders. This updated POV provides the latest thinking on this law and its implications for pharma marketers.

July 16, 2019

Six Ways Data Science Can Create More Efficient Marketing Experiences

Data science: a term that always sounds cutting-edge. While discussions of personalized medicine and the related science of gene therapy and similar advances become more science than science fiction, pharma marketing is beginning to step into the individualized, independent experience economy, as well. What is the experience economy? It’s not

December 6, 2018

GDPR, AI and Machine Learning in the Age of Data Privacy

As of May 2018, the implementation of the General Data Protection Regulation (GDPR) allows European consumers more “ownership” of their data and the ability to remove that data from marketing systems. This POV from Intouch innovation manager Andrew Grojean will answer these questions and provide recommendations for marketers leveraging AI in the new age of data privacy and security.

Load More Posts